BMY Bristol-Myers Squibb Company

NYSE
$58.80

Bristol-Myers Squibb Company (BMY) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with BMY's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 3 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
3
3 transactions
Purchases
$0
0 shares
Sales
$677.8K
10,549 shares
Net activity
-$677.8K
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $677.8K 3 transactions · 10,549 shares

Largest single sale: $403.5K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Haller Julia A Director Sell 3,800 $63.31 $240.6K 30,279 −11.2% of holding
Massacesi Cristian EVP,Chief Med Offr,Head of Dev Sell 6,249 $64.57 $403.5K 18,748 −25% of holding
Holzer Phil M SVP and Controller Sell 500 $67.50 $33.8K 16,862 −2.9% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.